Insider Selling: Targeted Medical Pharma CEO Sells 2,000 Shares of Stock (TRGM)
Targeted Medical Pharma (NASDAQ:TRGM) CEO William Shell unloaded 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $0.60, for a total transaction of $1,200.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Targeted Medical Pharma (NASDAQ:TRGM) traded up 16.67% on Wednesday, hitting $0.70. The stock had a trading volume of 26,706 shares. Targeted Medical Pharma has a one year low of $0.49 and a one year high of $1.98. The stock has a 50-day moving average of $0.72 and a 200-day moving average of $0.79. The company’s market cap is $18.5 million.
Targeted Medical Pharma Inc is a pharmaceutical company. The Company develops and commercializes nutrient- and pharmaceutical-based therapeutic systems.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.